Content
67%Weight 40%Scale 1-5Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
A well-structured, actionable skill body with concrete commands and clear outputs, weakened by repeated descriptions of the same pipeline and implicit rather than explicit validation/fallback checkpoints. No bundle files exist, so all content is inline in a single well-sectioned file.
Suggestions
Consolidate the duplicated pipeline description: 'Why This Exists', 'Core Capabilities', and 'Workflow' each restate photo-identification and the gzip capability — keep one authoritative workflow section and trim the rest.
Add explicit validation/fallback steps to the workflow: what to do when Claude vision cannot identify the drug, when fuzzy matching finds no candidate, or when the genotype file lacks the relevant gene (currently only the INSUFFICIENT DATA output label hints at this).
Move the 51-drug reference table and citations into a references/ file (e.g., references/drugs.md) to slim the SKILL.md overview, and clarify that pharmgx_reporter.py is a dependency from the sibling pharmgx-reporter skill since no scripts/ exist in this bundle.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | The body is mostly efficient (compact tables, command blocks), but the pill-identification flow is restated three times ("Why This Exists", "Core Capabilities", "Workflow") and "gzip-compressed .txt.gz supported" appears twice, so it could be tightened. | 3 / 5 |
Actionability | Concrete, copy-paste-ready CLI invocations with flags (--input patient.txt.gz --drug Plavix --dose 30mg), a runnable demo command, and an exact output card example. Minor gaps: the vision-identification step is delegated to an external agent, and pharmgx_reporter.py lives in a sibling skill rather than this bundle. | 4 / 5 |
Workflow Clarity | The 5-step Workflow (Photo → Resolve → Genotype → Lookup → Card) is clearly sequenced and failure outcomes are partially handled via the INSUFFICIENT DATA label, but validation checkpoints (e.g., what to do when vision cannot identify the drug or fuzzy matching fails) are implicit rather than explicit — so not a 5. | 4 / 5 |
Progressive Disclosure | Well-organized sections with no nested references and content that mostly fits inline (the 51-drug table is compact and central). Not a 5: the body is over 50 lines and the drug table plus citations could arguably live in a reference file, and there are no bundle files at all despite cross-skill references. | 4 / 5 |
Total | 15 / 20 Passed |